Central CRH system in depression and anxiety--evidence from clinical studies with CRH1 receptor antagonists.
about
Glucocorticoid dysregulations and their clinical correlates. From receptors to therapeuticsOrchestration of neurodevelopmental programs by RBFOX1: implications for autism spectrum disorderCorticotrophin-releasing factor 1 activation in the central amygdale and visceral hyperalgesiaBehavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism.Neuroinflammation at the interface of depression and cardiovascular disease: Evidence from rodent models of social stressEmerging drugs for the treatment of anxietyCurrent investigational drugs for major depressionEffect of lamotrigine and carbamazepine on corticotropin-releasing factor-associated serotonergic transmission in rat dorsal raphe nucleuscAMP-dependent cell differentiation triggered by activated CRHR1 in hippocampal neuronal cells.Mad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviorsThe CRH1 antagonist GSK561679 increases human fear but not anxiety as assessed by startle.Sex and exercise interact to alter the expression of anabolic androgenic steroid-induced anxiety-like behaviors in the mouse.Corticotropin-releasing factor modulation of forebrain GABAergic transmission has a pivotal role in the expression of anabolic steroid-induced anxiety in the female mouse.Chronic anabolic androgenic steroid exposure alters corticotropin releasing factor expression and anxiety-like behaviors in the female mouseInhibition of corticotropin releasing factor expression in the central nucleus of the amygdala attenuates stress-induced behavioral and endocrine responses.Major depression is not associated with blunting of aversive responses; evidence for enhanced anxious anticipation.Human fear acquisition deficits in relation to genetic variants of the corticotropin releasing hormone receptor 1 and the serotonin transporterPersistent anxiolytic affects after chronic administration of the CRF₁ receptor antagonist R121919 in rats.Prenatal Cocaine Disrupts Serotonin Signaling-Dependent Behaviors: Implications for Sex Differences, Early Stress and Prenatal SSRI ExposureRole of CRF receptor signaling in stress vulnerability, anxiety, and depression.Progress in corticotropin-releasing factor-1 antagonist development.CRF1 and CRF2 receptors are required for potentiated startle to contextual but not discrete cuesAllergic rhinitis induces anxiety-like behavior and altered social interaction in rodents.Stress and depression: preclinical research and clinical implicationsNeurobiological mechanisms of addiction: focus on corticotropin-releasing factor.Neurobiological mechanisms contributing to alcohol-stress-anxiety interactions.B-Raf and CRHR1 internalization mediate biphasic ERK1/2 activation by CRH in hippocampal HT22 Cells.Hippocampal changes associated with early-life adversity and vulnerability to depression.Corticotropin-releasing factor-1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stress-induced relapseOxytocin and Major Depressive Disorder: Experimental and Clinical Evidence for Links to Aetiology and Possible TreatmentDeducing corticotropin-releasing hormone receptor type 1 signaling networks from gene expression data by usage of genetic algorithms and graphical Gaussian modelsOpen questions in current models of antidepressant action.Early attachment-figure separation and increased risk for later depression: potential mediation by proinflammatory processes.Individual differences in reactivity to social stress predict susceptibility and resilience to a depressive phenotype: role of corticotropin-releasing factorHypothalamic-pituitary-adrenal axis hypersensitivity in female rats on a post-weaning high-fat diet after chronic mild stress.Convergence of neuro-endocrine-immune pathways in the pathophysiology of irritable bowel syndrome.COMORBIDITY BETWEEN DEPRESSIVE AND ADDICTIVE DISORDERS IN ADOLESCENTS: ROLE OF STRESS AND HPA ACTIVITY.Alternative strategies for the treatment of classical congenital adrenal hyperplasia: pitfalls and promisesLongitudinal course of adolescent depression: neuroendocrine and psychosocial predictors.Role of bed nucleus of the stria terminalis corticotrophin-releasing factor receptors in frustration stress-induced binge-like palatable food consumption in female rats with a history of food restriction.
P2860
Q24618470-89491CD0-5935-497A-8131-2C777ED1B66EQ26853067-0CC23593-EA70-40FC-B284-824F7C3DD1CAQ26864379-190A3538-FF8F-4D5B-AB10-6A4ABE1EC688Q27014879-44529039-BEA6-4040-AFA3-426EF06FDAA7Q28069771-4DA8F12D-8FF0-46E8-869F-D1AD27F9C65AQ28083141-5E00EDEE-BBDE-4C81-BEBD-7D2E48667A26Q28244223-C4F507B6-DCC6-4EC8-9B8B-592E226E4FFFQ28564629-95702429-6DF4-4A73-AB31-F9DA23C3CAD9Q29994681-E8A2C58E-34C7-4293-9BCD-C7A85B25E0E3Q30364736-A61CA507-1934-4055-9856-B69115EA12B6Q30387331-27E86366-F6B4-4F87-A258-E5985FB7E285Q30407853-2A21626A-5F68-4A71-859D-6AAED5D680B2Q30419669-18471877-81BC-4711-BF46-C3EE2FC4264EQ30430100-3B65A899-A50E-4813-BD4C-044A4752E604Q30447564-F690A3EB-5935-4550-8EEA-6926AD8E841FQ30450782-155BE81F-B0D9-4D26-B8C8-3771AAB68653Q30454352-CACE82F0-F3A1-40F4-B7CA-1F6EC5E40EBAQ30467178-5BFC6096-B6C5-4EE4-864E-80E060A152BEQ30469931-60FC14C9-F941-46B6-9934-5780A181A4DCQ30475129-CD9B973B-DC07-48E7-8338-519DF71A011FQ30475627-7DB0ADB3-FB40-43D4-8B79-9BFB42A9A53CQ30480573-3782D979-10F4-40E6-99D4-C0897E742EBCQ30490177-3F9113C4-DE8F-4A1F-A0F6-69A34FDB34E9Q33404098-05AD3428-07F1-473A-A473-CC24327A9EA4Q33616639-0B7DF890-2A14-4DDC-B0C7-CEA70C98C148Q33622357-B33BE16E-5BE0-4BB9-868D-40B3E059D486Q33636207-46EC9764-09A8-4CDA-A149-4BEFD0437B95Q33649329-14EA9226-8B85-4331-8E9A-2B088E84D25AQ33656596-E4F1842E-2C59-4FB3-866F-C5C6D04049D7Q33664227-A940F35D-1510-4CB8-9F41-1ACA1A8B054BQ33751836-481086C4-5488-4B36-8E3C-CCE87F99CC97Q33767182-8ACA4AA3-0AC7-4101-8814-02FC1A0F8404Q33767298-26458247-7F48-404F-B056-2AC46D807594Q33772332-74061249-EA97-4B95-84B6-FED999BF1C10Q33846539-631D37A3-3D15-4547-A17F-40A37423A4C5Q33958801-83A9C320-9B5A-4A4E-8744-7C8DEE062BD3Q33989571-0456DB31-DE94-4CBC-BE2B-125B32F37AFDQ34002823-F07D2F7B-EE15-46B7-9130-8C19D1827F04Q34010156-390B0274-8B8F-4BAF-A8C1-CBFC8E534245Q34067338-7191434D-A674-448D-AA29-95B49E605E3B
P2860
Central CRH system in depression and anxiety--evidence from clinical studies with CRH1 receptor antagonists.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Central CRH system in depressi ...... ith CRH1 receptor antagonists.
@ast
Central CRH system in depressi ...... ith CRH1 receptor antagonists.
@en
Central CRH system in depressi ...... ith CRH1 receptor antagonists.
@nl
type
label
Central CRH system in depressi ...... ith CRH1 receptor antagonists.
@ast
Central CRH system in depressi ...... ith CRH1 receptor antagonists.
@en
Central CRH system in depressi ...... ith CRH1 receptor antagonists.
@nl
prefLabel
Central CRH system in depressi ...... ith CRH1 receptor antagonists.
@ast
Central CRH system in depressi ...... ith CRH1 receptor antagonists.
@en
Central CRH system in depressi ...... ith CRH1 receptor antagonists.
@nl
P1476
Central CRH system in depressi ...... ith CRH1 receptor antagonists.
@en
P304
P356
10.1016/J.EJPHAR.2007.12.032
P407
P577
2008-01-24T00:00:00Z